SBIR/STTR Research Award

NOVEL BIOACTIVE GLASS DENTIFRICE FORMULATIONS

Award identifier 49f136b282f1c14ca6b98ad633d3bdb5a24a40ea27f4e1f30c08ef15a6c83392Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$98,527

Program and phase

SBIR · Phase I

Award year

2002

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
USBIOMATERIALS CORPORATION
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): The Long-term goal of this research is to develop novel dentifrice formulations containing bioactive glasses that will replace or be an adjuvant to fluoride as an anti-cares agent. The initial focus of the research will be to develop reduced fluoride formulations which have equivalent or superior anti-caries efficacy to commercially available formulation. These formulations will be beneficial to the general population and to segments of the population where the potential benefits of using a standard fluoride dentifrice formulation is reduced. Bioactive glasses have been successfully used clinically as a bone grafting material for over fifteen years. Recently it has been documented that fine particulate bioactive glasses incorporated into an aqueous dentifrice have demonstrated an ability to clinically reduce tooth hypersensitivity through the occlusion of dentinal tubules. In vitro studies have demonstrated significant occlusions and remineralization of prepared bovine dentin and remineralization of precarious surface lesions. Other in vitro studies have demonstrated significant anti-microbial effect towards caries pathogens. The Specific Aims of this Phase I application are to: 1) test single phase anhydrous and dual phase aqueous dentifrice formulations to characterize their efficacy, 2) conduct accelerated stability testing of the most promising formulations, 3) test selected formulations from Aim 2 for anti-microbial activity and, 4) evaluate them using established in vitro subsurface caries models to predict in vivo efficacy.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.